Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Probiotics
15 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Probiotics
Applying Synthetic Biology to Elevate Probiotics
PAO-04-22-R250-10
Drug Delivery
Bringing Novel Delivery Technologies to the North American Market
PAP-Q4-19-CL-020
Market Prediction
Dissection of the Global $73+ Billion Probiotics Market by 2024
PR-M05-19-NI-044
Probiotics
Evolve BioSystems Makes Evivo Available in Hong Kong, Singapore
PR-M05-19-NI-023
Probiotics
HUM Nutrition Introduces Pre and Probiotic Supplement Formulated for Acne-prone (Non-cystic) and Dry Skin After Concluding Consumer Study
PR-M04-19-NI-027
Probiotics
Megabiotic™-44, a Pre and Postbiotics Complex, from Lactobacillus Bulgaricus GLB44, Microorganism Able to Enhance Pore Refinement
PR-M04-19-NI-018
Probiotics
Scientists Clarify What Probiotics Are
PR-M03-19-NI-048
Probiotics
The Probiotics Market is Estimated to be Valued at 45.64 Billion in 2017, and Projected to Grow at a CAGR of 7.0%, to Reach USD 64.02 Billion by 2022
PR-M01-19-NI-068
Probiotics
Hard-Shell Capsule Solutions for Sensitive Compounds: A Focus on Probiotics
PAO-M12-18-CL-002
Probiotics
Probiotic Ingredients Market Worth Over $3 Billion by 2024: Global Market Insights, Inc.
PR-M11-18-NI-103
Probiotics
Visiongain Report Researches Growth Opportunities Within the $59bn Global Probiotics Market
PR-M11-18-NI-033
Drug Development
Bacteria in the Stomach Found to Play a Role in Multiple Sclerosis
PAO-M05-18-NI-016
Investment
Kaneka has invested in AB-Biotics SA, a Spanish biotech company and concluded a license agreement for production and sales of its probiotics products
PR-M05-18-NI-067
Drug Development
Partnership to Develop Clostridial-Based Medicines Moves Forward
PR-M03-18-NI-104
Probiotics
J&J Involved in Probiotics Development Program
PR-M03-18-NI-100
.svg)
